BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15856465)

  • 1. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation.
    Lu S; Yu G; Zhu Y; Archer MC
    Int J Cancer; 2005 Oct; 116(6):847-52. PubMed ID: 15856465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.
    Komatsu K; Buchanan FG; Katkuri S; Morrow JD; Inoue H; Otaka M; Watanabe S; DuBois RN
    Gastroenterology; 2005 Aug; 129(2):577-90. PubMed ID: 16083714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells.
    Singh B; Vincent L; Berry JA; Multani AS; Lucci A
    J Surg Res; 2007 Jun; 140(2):220-6. PubMed ID: 17418864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cells.
    Lareef MH; Tahin Q; Song J; Russo IH; Mihaila D; Slater CM; Balsara B; Testa JR; Broccoli D; Grobelny JV; Mor G; Cuthbert A; Russo J
    Mol Carcinog; 2004 Apr; 39(4):234-46. PubMed ID: 15057875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue.
    Gauthier ML; Pickering CR; Miller CJ; Fordyce CA; Chew KL; Berman HK; Tlsty TD
    Cancer Res; 2005 Mar; 65(5):1792-9. PubMed ID: 15753376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 overexpression increases motility and invasion of breast cancer cells.
    Singh B; Berry JA; Shoher A; Ramakrishnan V; Lucci A
    Int J Oncol; 2005 May; 26(5):1393-9. PubMed ID: 15809733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
    Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
    Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclooxygenase-2 antisense vector on proliferation of human cholangiocarcinoma cells.
    Wu GS; Zou SQ; Wu XY; Qiu FZ
    Chin Med Sci J; 2004 Jun; 19(2):89-92. PubMed ID: 15250241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.
    Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD
    Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine characteristics of human breast epithelial cells, MCF-10F.
    Singhal H; Guo L; Bradlow HL; Mittelman A; Tiwari RK
    Horm Res; 1999; 52(4):171-7. PubMed ID: 10725782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.
    Munkarah AR; Morris R; Baumann P; Deppe G; Malone J; Diamond MP; Saed GM
    J Soc Gynecol Investig; 2002; 9(3):168-73. PubMed ID: 12009392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained co-cultivation with human placenta-derived MSCs enhances ALK5/Smad3 signaling in human breast epithelial cells, leading to EMT and differentiation.
    Yoo YA; Kang MH; Kim BS; Kim JS; Seo JH
    Differentiation; 2009 Jun; 77(5):450-61. PubMed ID: 19375841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells.
    Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB
    Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.